RECENT NEWS
Hims & Hers stock slipped as investors were left unimpressed with its new weight-loss drug options
Eli Lilly is coming after makers of copycat versions of Zepbound
Cheaper Wegovy, 23andMe shutters, and RFK Jr. cuts FDA jobs: Pharma news roundup
Wegovy sales took a hit this year. Novo's CEO blames off-brand competition